Abstract
The p53 homologue p73 efficiently activates p53-responsive genes. The well documented over-expression of p73 spliced forms in a wide variety of tumor types promoted us to elucidate the mechanisms underlying p73-mediated transcription. Using the luciferase reporter gene driven by Mdm2-minimal promoter in p53 null cells, we demonstrate that the weak transcriptional activity mediated by p73α was increased by the mutant form p73β292, which by itself is transcriptionally inactive. Similarly, cooperation between p73β and an inactive form of p73α increased p73β-mediated transcriptional activities. Conversely, p73β elicited a silencing effect on a gain of function mutant, p53281, which by itself mediated efficient transactivation of the MDR promoter. Neither anisomycin nor actinomycin D altered p73-mediated transcriptional activities, whereas sorbitol profoundly inhibited them through a rapid proteasome-dependent degradation of p73. Our observations point to plausible scenarios in which p73, through cooperation between p73 spliced forms and suppression of gain of function mutant p53 may elicit changes in the transcription of p53 target genes that play key roles in cell growth and death.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Blandino G, Levine AJ and Oren M. . 1999 Oncogene 18: 477–485.
De Laurenzi V, Costanzo A, Barcaroli D, Terrinoni A, Falco M, Annicchiarico-Petruzzelli M, Levrero M and Melino G. . 1998 J. Exp. Med. 188: 1763–1768.
Di Como CJ, Gaiddon C and Prives C. . 1999 Mol. Cell. Biol. 19: 1438–1449.
Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C and Levine AJ. . 1993 Nat. Genet. 4: 42–46.
Dobbelstein M, Wienzek S, Konig C and Roth J. . 1999 Oncogene 18: 2101–2106.
El-Diery WS, Tokino T, Veculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. . 1993 Cell 75: 817–825.
Gorgoulis VG, Zacharatos PV, Manolis E, Ikonomopoulos JA, Damalas A, Lamprinopoulos C, Rassidakis GZ, Zoumpourlis V, Kotsinas A, Rassidakis AN, Halazonetis TD and Kittas C. . 1998 Br. J. Cancer 77: 374–384.
Gualberto A, Aldape K, Kozakiewicz K and Tlsty TD. . 1998 Proc. Natl. Acad. Sci. USA 95: 5166–5171.
Han S, Semba S, Abe T, Makino N, Furukawa T, Fukushige S, Takahashi H, Sakurada A, Sato M, Shiiba K, Matsuno S, Nimura Y, Nakagawara A and Horii A. . 1999 Eur. J. Surg. Oncol. 25: 194–198.
Harvey M, Vogel H, Morris D, Bradley A, Bernstein A and Donehower LA. . 1995 Nat. Genet. 9: 305–311.
Iwamoto KS, Mizuno T, Ito T, Tsuyama N, Kyoizumi S and Seyama T. . 1996 Cancer Res. 56: 3862–3865.
Jost CA, Marin MC and Kaelin WGJ. . 1997 Nature 389: 191–194.
Kaelin WG Jr. . 1999 J. Natl. Cancer. Inst. 91: 594–598.
Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D. . 1997 Cell 90: 809–819.
Kovalev S, Marchenko N, Swendeman S, LaQuaglia M and Moll UM. . 1998 Cell Growth Differ. 9: 897–903.
Lanyi A, Deb D, Seymour RC, Ludes-Meyers JH, Subler MA and Deb S. . 1998 Oncogene 16: 3169–3176.
Lee CW and La Thangue NB. . 1999 Oncogene 18: 4171–4181.
Levine AJ. . 1997 Cell 88: 323–331.
Lomax ME, Barnes DM, Hupp TR, Picksley SM and Camplejohn RS. . 1998 Oncogene 17: 643–649.
Lotem J and Sachs L. . 1995 Proc. Natl. Acad. Sci. USA 92: 9672–9676.
Mai M, Huang H, Reed C, Qian C, Smith JS, Alderete B, Jenkins R, Smith DI and Liu W. . 1998b Genomics 51: 359–363.
Mai M, Qian C, Yokomizo A, Tindall DJ, Bostwick D, Polychronakos C, Smith DI and Liu W. . 1998c Oncogene 17: 1739–1741.
Mai M, Yokomizo A, Qian C, Yang P, Tindall DJ, Smith DI and Liu W. . 1998a Cancer Res. 58: 2347–2349.
Marin MC, Jost CA, Irwin MS, Decaprio JA, Caput D and Kaelin WGJ. . 1998 Mol. Cell. Biol. 18: 6316–6324.
Oren M. . 1997 Cell 90: 829–832.
Oren M and Prives C. . 1996 Biochem. Biophys. Acta. Rev. Cancer 1288: R13–R19-2.
Osada M, Ohba M, Kawahara C, Isioka C, Kanamaru R, Katoh I, Ikawa Y, Nimura Y, Nakagawara A, Obinata M and Ikawa S. . 1998 Nat. Med. 4: 839–843.
Polyak K, Xia Y, Zweier J, Kinzler K and Vogelstein B. . 1997 Nature 389: 300–305.
Prabhu NS, Somasundaram K, Satyamoorthy K, Herlyn M and El-Deiry WS. . 1998 Int. J. Oncol. 13: 5–9.
Roth J, Konig C, Wienzek S, Weigel S, Ristea S and Dobbelstein M. . 1998 J. Virol. 72: 8510–8516.
Smith PD, Crossland S, Parker G, Osin P, Brooks L, Waller J, Philp E, Crompton MR, Gusterson BA, Allday MJ and Crook T. . 1999 Oncogene 18: 2451–2459.
Steegenga WT, Shvarts A, Riteco N, Bos JL and Jochemsen AG. . 1999 Mol. Cell. Biol. 19: 3885–3894.
Stenger JE, Tegtmeyer P, Mayr GA, Reed M, Wang Y, Wang P, Hough PV and Mastrangelo IA. . 1994 EMBO J. 13: 11–20.
Sugano T, Nitta M, Ohmori H and Yamaizumi M. . 1995 Jpn. J. Cancer Res. 86: 415–418.
Sunahara M, Ichimiya S, Nimura Y, Takada N, Sakiyama S, Sato Y, Todo S, Adachi W, Amano J and Nakagawara A. . 1998 Int. J. Oncol. 13: 319–323.
Takahashi H, Ichimiya S, Nimura Y, Watanabe M, Furusato M, Wakui S, Yatani R, Aizawa S and Nakagawara A. . 1998 Cancer Res. 58: 2076–2077.
Tsao H, Zhang X, Majewski P and Haluska FG. . 1999 Cancer Res. 59: 172–174.
Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D and McKeon F. . 1998 Mol. Cell. 2: 305–316.
Yokomizo A, Mai M, Tindall DJ, Cheng L, Bostwick DG, Naito S, Smith DI and Liu W. . 1999a Oncogene 18: 1629–1633.
Yokomizo A, Mai M, Bostwick DG, Tindall DJ, Qian J, Cheng L, Jenkins RB, Smith DI and Liu W. . 1999b Prostate 9: 94–100.
Zeng X, Chen L, Jost CA, Maya R, Keller D, Wang X, Kaelin WG Jr, Oren M, Chen J and Lu H. . 1999 Mol. Cell. Biol. 19: 3257–3266.
Zhu J, Jiang J, Zhou W and Chen Z. . 1998 Cancer Res. 58: 5061–5065.
Acknowledgements
We thank W Kaelin Jr. for the p73 constructs. Support from NCI grant CA78419 (to Z Ronai) is gratefully acknowledged.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Alarcon-Vargas, D., Fuchs, S., Deb, S. et al. p73 transcriptional activity increases upon cooperation between its spliced forms. Oncogene 19, 831–835 (2000). https://doi.org/10.1038/sj.onc.1203311
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203311
Keywords
This article is cited by
-
p53-independent mechanisms regulate the P2-MDM2 promoter in adult astrocytic tumours
British Journal of Cancer (2008)
-
p73 expression modulates p63 and Mdm2 protein presence in complex with p53 family-specific DNA target sequence in squamous cell carcinogenesis
Oncogene (2008)
-
Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia
Leukemia (2006)